{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:50:04Z","timestamp":1781715004917,"version":"3.54.5"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction and Hypothesis<\/jats:title>\n                    <jats:p>Isolated mesh-associated pain syndrome (I-MAPS) is the commonest reason why women access mesh-complication services. Qualitative work exploring expectations of women with I-MAPS is limited. We aimed to explore the concerns and goals of women with I-MAPS who accessed care at a quaternary-level mesh service to ensure that services are designed to meet their needs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 280 women with I-MAPS related to a single continence device, were invited to provide free-text comments on concerns and goals related to their mesh complication using the Electronic Patient Assessment Questionnaire (e-PAQ). Of 280 participants, 203 completed the e-PAQ (response proportion 73%) and 179 (response proportion 64%) provided comments. Thematic analysis was performed based on the methodology proposed by Braun and Clarke.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Thirty-eight codes were developed, and 109 sub-codes. These defined eight core themes. Concerns regarding pain accounted for 22% of comments (106 out of 489). Concerns about pelvic floor symptoms featured heavily in comments. Symptom resolution was desired by most; however, a proportion requested symptom reduction. Mesh-removal surgery was a common goal pursued; however, a proportion wished information about the safety and future threat of mesh devices.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Patients with I-MAPS appear to have concerns unrelated to pain including pelvic floor dysfunction and these may be the primary motivation for accessing mesh services. Although mesh removal was a motivation for many, it was not requested by all. This highlights the importance of services offering individualised and holistic care through multidisciplinary team involvement.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00192-025-06323-7","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T08:53:25Z","timestamp":1761036805000},"page":"663-671","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Concerns and Goals of Women with Isolated Mesh-Associated Pain Syndrome Accessing a Quaternary Mesh Referral Service: A Thematic Analysis"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0136-7683","authenticated-orcid":false,"given":"Hawra","family":"Badri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Dwyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Serridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelechi","family":"Ajoku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Edmondson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"issue":"4","key":"6323_CR1","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S0029-7844(97)00058-6","volume":"89","author":"AL Olsen","year":"1997","unstructured":"Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol. 1997;89(4):501\u20136.","journal-title":"Obstet Gynecol"},{"key":"6323_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j5515","volume":"7","author":"C Heneghan","year":"2017","unstructured":"Heneghan C, Aronson JK, Goldacre B, Mahtani KR, Pl\u00fcddemann A, Onakpoya I. Transvaginal mesh failure: lessons for regulation of implantable devices. BMJ. 2017;7:j5515.","journal-title":"BMJ"},{"key":"6323_CR3","unstructured":"Scientific Committee on Emerging and Newly Identified Health Risks. Available from: https:\/\/ec.europa.eu\/health\/sites\/health\/files\/scientific_committees\/emerging\/docs\/scenihr_o_049.pdf.\u00a0Accessed 5 May 2025"},{"key":"6323_CR4","unstructured":"NHS England Mesh Oversight Group Report. www.england.nhs.uk. Available from: https:\/\/www.england.nhs.uk\/publication\/meshoversight-group-report\/2017.\u00a0Accessed 5 May 2025"},{"issue":"5","key":"6323_CR5","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.eururo.2009.01.055","volume":"55","author":"F Daneshgari","year":"2009","unstructured":"Daneshgari F. Re: FDA public health notification: serious complications associated with transvaginal placement of surgical mesh in repair of pelvic organ prolapse and stress urinary incontinence. Eur Urol. 2009;55(5):1235\u20136.","journal-title":"Eur Urol"},{"key":"6323_CR6","unstructured":"Engeler D, Baranowski A, Berghmans B, Birch J, Borovicka J, Cottrell A, et al. EAU guidelines on chronic pelvic pain. Available from: https:\/\/d56bochluxqnz.cloudfront.net\/documents\/full-guideline\/EAU-Guidelines-on-Chronic-Pelvic-Pain-2024.pdf."},{"issue":"1","key":"6323_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-025-03916-8","volume":"25","author":"H Badri","year":"2025","unstructured":"Badri H, Rajai A, Ward K, Edmondson R, Reid F. The management of vaginal prolapse and stress incontinence mesh complications in a quaternary mesh complications service in the United Kingdom (U.K): a 5-year observational study. BMC Womens Health. 2025;25(1):381. https:\/\/doi.org\/10.1186\/s12905-025-03916-8.","journal-title":"BMC Womens Health"},{"key":"6323_CR8","unstructured":"Cumberlege J. First Do No Harm. The report of the independent medicines and medical devices safety review. Available from: https:\/\/www.immdsreview.org.uk\/downloads\/IMMDSReview_Web.pdf.\u00a0Accessed June 2025"},{"key":"6323_CR9","unstructured":"Department of Health and Social Care. Women\u2019s health strategy for England. Available from: https:\/\/www.gov.uk\/government\/publications\/womens-health-strategy-for-england\/womens-health-strategy-for-england.\u00a0Accessed 2025"},{"issue":"2","key":"6323_CR10","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qualit Res Psychol. 2006;3(2):77\u2013101. https:\/\/doi.org\/10.1191\/1478088706qp063oa.","journal-title":"Qualit Res Psychol"},{"key":"6323_CR11","unstructured":"Department for Communities and Local Government. The English Index of Multiple Deprivation (IMD) 2015 guidance. Available from: https:\/\/assets.publishing.service.gov.uk\/media\/5a7f0e5ded915d74e33f410b\/English_Index_of_Multiple_Deprivation_2015_-_Guidance.pdf.\u00a0Accessed 2025"},{"issue":"1","key":"6323_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6874-10-18","volume":"10","author":"M Pakbaz","year":"2010","unstructured":"Pakbaz M, Persson M, L\u00f6fgren M, Mogren I. \u201cA hidden disorder until the pieces fall into place\u201d\u2014a qualitative study of vaginal prolapse. BMC Womens Health. 2010;10(1):18.","journal-title":"BMC Womens Health"},{"issue":"7","key":"6323_CR13","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1111\/j.1471-0528.2005.00568.x","volume":"112","author":"GA Digesu","year":"2005","unstructured":"Digesu GA, Chaliha C, Salvatore S, Hutchings A, Khullar V. The relationship of vaginal prolapse severity to symptoms and quality of life. BJOG. 2005;112(7):971\u20136.","journal-title":"BJOG"},{"issue":"1","key":"6323_CR14","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/1471-0528.16331","volume":"128","author":"M Izett-Kay","year":"2020","unstructured":"Izett-Kay M, Lumb C, Cartwright R, Kupelian A, Cutner A, Jackson S, et al. \u201cWhat research was carried out on this vaginal mesh?\u201d Health-related concerns in women following mesh-augmented prolapse surgery: a thematic analysis. BJOG. 2020;128(1):131\u20139.","journal-title":"BJOG"},{"key":"6323_CR15","unstructured":"General Medical Council (GMC). Guidance on professional standards and ethics for doctors decision making and consent. General Medical Council. Available from: https:\/\/www.gmc-uk.org\/-\/media\/documents\/gmc-guidance-for-doctors---decision-making-and-consent-english_pdf-84191055.pdf.\u00a0Accessed 2025"},{"key":"6323_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2020.113151","volume":"260","author":"A Ducey","year":"2020","unstructured":"Ducey A, Donoso C, Ross S, Robert M. From anatomy to patient experience in pelvic floor surgery: mindlines, evidence, responsibility, and transvaginal mesh. Soc Sci Med. 2020;260:113151.","journal-title":"Soc Sci Med"},{"issue":"6","key":"6323_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2024-085879","volume":"14","author":"ACDC Williams","year":"2024","unstructured":"Williams ACDC, Lodato M, McGrigor H. Pain and other complications of pelvic mesh: a systematic review of qualitative studies and thematic synthesis of women\u2019s accounts. BMJ Open. 2024;14(6):e085879.","journal-title":"BMJ Open"},{"key":"6323_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.101918","volume":"58","author":"F Toye","year":"2023","unstructured":"Toye F, Izett-Kay M, Barker KL, McNiven A. The experience of women reporting damage from vaginal mesh: a reflexive thematic analysis. eClinicalMedicine. 2023;58:101918.","journal-title":"eClinicalMedicine"},{"issue":"3","key":"6323_CR19","first-page":"1","volume":"16","author":"MS Hagger","year":"2021","unstructured":"Hagger MS, Orbell S. The common-sense model of illness self-regulation: a conceptual review and proposed extended model. Health Psychol Rev. 2021Feb 1;16(3):1\u201331.","journal-title":"Health Psychol Rev"},{"issue":"2","key":"6323_CR20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s40271-021-00547-7","volume":"15","author":"M Motamedi","year":"2021","unstructured":"Motamedi M, Carter SM, Degeling C. Women\u2019s experiences of and perspectives on transvaginal mesh surgery for stress urine incontinency and pelvic organ prolapse: a qualitative systematic review. Patient. 2021;15(2):157\u201369. https:\/\/doi.org\/10.1007\/s40271-021-00547-7.","journal-title":"Patient"}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-025-06323-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00192-025-06323-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-025-06323-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T13:17:49Z","timestamp":1774703869000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00192-025-06323-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["6323"],"URL":"https:\/\/doi.org\/10.1007\/s00192-025-06323-7","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"10 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. All assessments performed were part of routine clinical care and anonymised data presented here were collected for service and quality improvement purposes. Research Ethics Approval was hence not necessary.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human Ethics and Consent to Participate"}},{"value":"R.E.: none related to this work. Has received honoraria within the last 3\u00a0years from Astra Zeneca, Glaxo SmithKline and Clovis Pharmaceuticals. F.R.: none related to this work. Has received funding from Health Technology Assessment within the last 3\u00a0years. The other authors have no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}]}}